1 / 7

Head & Neck Cancer Drugs Market

Market is classified into hospital pharmacies, drug stores & retail pharmacies, and online stores. The online providers segment is expected to experience fastest growth over the forecast period due to rise in preference for online purchasing of drugs over the traditional methods, increase in number of internet users, and growth in awareness about online pharmacy. However, drug stores & retail pharmacies segment dominated the market in 2017 due to its higher presence.

Sanyukta_K
Télécharger la présentation

Head & Neck Cancer Drugs Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Download Report Sample

  2. The global head & neck cancer drugs market was valued at $1,295 million in 2017, and is projected to reach $2,281 million by 2025, registering a CAGR of 7.3% from 2018 to 2025. Head & neck cancers include a number of different malignant tumors that develop in or around the throat, larynx, nose, sinuses, lips, salivary glands, and mouth. There are different types of drugs used alone or in combination for treatment of head & neck cancer. Although traditional chemotherapeutic drugs preferably used in combination of radiation therapy, targeted immune therapies are emerging as a standard treatment option for advanced-stage head & neck cancers. Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/5174 Head & Neck Cancer Drugs Market Download Report Sample

  3. Increase in prevalence of head & neck cancer across geographies, rise in demand for combination therapy for management of head & neck cancer, and growth in number of R&D activities to develop ideal therapeutic drive the growth of the global head & neck cancer drugs market. Furthermore, technological advancements in screening procedure for cancer and strong presence of pipeline drugs such as Ipilimumab, Atezolizumab, Avelumab, Durvalumab, Erlotinib, Afatinib, Bevacizumab, and others are expected to drive the market growth. The global head & neck cancer drugs market is segmented based on drug class, sales channel, and region. Based on drug class, the market is classified into chemotherapy, immunotherapy, and targeted therapy. According to the sales channel, it is categorized into hospital pharmacies, drug stores & retail pharmacies, and online stores. Based on region, the head and neck cancer drugs market size is studied across North America, Europe, Asia-Pacific and LAMEA. Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/5174 Head & Neck Cancer Drugs Market Download Report Sample

  4. Based on sales channel, the market is classified into hospital pharmacies, drug stores & retail pharmacies, and online stores. The online providers segment is expected to experience fastest growth over the forecast period due to rise in preference for online purchasing of drugs over the traditional methods, increase in number of internet users, and growth in awareness about online pharmacy. However, drug stores & retail pharmacies segment dominated the market in 2017 due to its higher presence. Asia-Pacific presents lucrative growth opportunities for the key players operating in the head & neck cancer drugs market owing to large population base, surge in incidence of head & neck cancer, and increase in demand for head & neck cancer combination therapeutics. Risk factors such as growth in alcohol consumption, increase in cigarette smoking, and higher usage of tobacco are further expected to fuel the market growth. Customization request @ https://www.alliedmarketresearch.com/request-for-customization/5174 Head & Neck Cancer Drugs Market Download Report Sample

  5. The Major Key Players Are: • AstraZeneca Plc. • Bristol-Myers Squibb Company • Eli Lilly and Company • F. Hoffmann-La Roche Ltd. (Genentech, Inc.,) • Fresenius Medical Care AG & Co. KGaA • Merck & Co., Inc. • Pfizer Inc. • Sanofi • Sun Pharmaceutical Industries Ltd. • Teva Pharmaceutical Industries Limited Head & Neck Cancer Drugs Market Download Report Sample

  6. Key Findings of the Study: • Based on sales channel, the online stores segment is expected to experience fastest market and is projected to grow at a CAGR of 10.2% during the forecast period 2018-2025. • On drug class, the chemotherapy segment held nearly half of the global market share in 2017, and is projected to grow at a CAGR of 4.0% from 2018 to 2025. • Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 9.7% during the forecast period Head & Neck Cancer Drugs Market Download Report Sample

  7. Contact: David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States Toll Free (USA/Canada): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1-855-550-5975 help@alliedmarketresearch.com Web: https://www.alliedmarketresearch.com Head & Neck Cancer Drugs Market Download Report Sample

More Related